Comments
The Government will consider 31 foreign investment proposals, including that of Ratnakar Bank, Novartis Healthcare and HDFC Bank, on December 16.
Of the 31 items on the agenda, nine are those on which the Foreign Investment Promotion Board (FIPB) had deferred a decision in its earlier meetings.
The nine proposals are Pureplay Investment Partners (Mauritius), INX Music, ASV Europa Security Pvt Ltd, Halyard Health Inc (US), Beloor Bayir Biotech, Tevapharm India Pvt, GMU Infosoft Pvt, U Infosoft Pvt Ltd, and Monsoon Capital LLC, US.
Other investment proposals include that of Lausanne Hospitality Consulting Sa, Switzerland, Sprint Telecom India, Maham Nayyar and Miss Sahar Nayyer, Pakistan, and Symbiotec Pharmalab.
While India allows FDI in most of the sectors through automatic route, FIPB approval required in certain sectors like pharmaceutical and defence, considered sensitive for the economy.
The government has taken several steps to boost FDI in the country. It has de-licensed several defence products for private players, besides hiking the FDI cap to 49 per cent in the sector.
Railways sector too has been opened to foreign investment and the government intends to hike FDI ceiling in insurance sector to 49 per cent from the current 26 per cent.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.